Legal & General Group
TTPH

Legal & General Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Legal & General Group’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-342
Closed -$3K – 3467
2019
Q2 		$3K Hold
342
– – ﹤0.01% 3474
2019
Q1 		$9K Hold
342
– – ﹤0.01% 3270
2018
Q4 		$8K Hold
342
– – ﹤0.01% 3296
2018
Q3 		$19K Hold
342
– – ﹤0.01% 3230
2018
Q2 		$24K Sell
342
-137
-29% -$9.67K ﹤0.01% 3122
2018
Q1 		$29K Sell
479
-175
-27% -$15.4K ﹤0.01% 3001
2017
Q4 		$82K Sell
654
-64
-9% -$8.2K ﹤0.01% 2681
2017
Q3 		$98K Buy
718
+220
+44% +$29.4K ﹤0.01% 2669
2017
Q2 		$75K Hold
498
– – ﹤0.01% 2759
2017
Q1 		$92K Sell
498
-117
-19% -$13.1K ﹤0.01% 2597
2016
Q4 		$51K Buy
615
+342
+125% +$27.1K ﹤0.01% 2889
2016
Q3 		$21K Sell
273
-65
-19% -$5.21K ﹤0.01% 2810
2016
Q2 		$29K Hold
338
– – ﹤0.01% 2762
2016
Q1 		$30K Hold
338
– – ﹤0.01% 2591
2015
Q4 		$68K Hold
338
– – ﹤0.01% 2293
2015
Q3 		$51K Buy
338
+65
+24% +$47.7K ﹤0.01% 2441
2015
Q2 		$243K Buy
273
+73
+37% +$59.7K ﹤0.01% 1660
2015
Q1 		$148K Hold
200
– – ﹤0.01% 1807
2014
Q4 		$163K Sell
200
-16
-7% -$8.61K ﹤0.01% 1693
2014
Q3 		$87K Buy
+216
New +$57.8K ﹤0.01% 1985

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Legal & General Group's TTPH Position: Q3 2019 in Review

Legal & General Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 342 shares — an estimated $3K sold.

Legal & General Group first reported a position in TTPH in Q3 2014 and held it in 20 quarters. The position peaked at $243K in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

  • Legal & General Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Legal & General Group sold 342 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $3K.
  • Legal & General Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2014 and held it in 20 quarters.
  • Legal & General Group's Tetraphase Pharmaceuticals, Inc. position peaked at $243K in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Legal & General Group's 13F filing for Q3 2019, filed 13 Nov 2019.